Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1994 Aug;72(2 Suppl):S51–S53. doi: 10.1136/hrt.72.2_suppl.s51

Neuroendocrine effects of diuretics in heart failure

P A Van Zwieten 1
PMCID: PMC1025576  PMID: 7946760

Full text

PDF
S51

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cody R. J., Atlas S. A., Laragh J. H., Kubo S. H., Covit A. B., Ryman K. S., Shaknovich A., Pondolfino K., Clark M., Camargo M. J. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest. 1986 Nov;78(5):1362–1374. doi: 10.1172/JCI112723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cohn J. N., Levine T. B., Olivari M. T., Garberg V., Lura D., Francis G. S., Simon A. B., Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984 Sep 27;311(13):819–823. doi: 10.1056/NEJM198409273111303. [DOI] [PubMed] [Google Scholar]
  3. Creager M. A., Faxon D. P., Cutler S. S., Kohlmann O., Ryan T. J., Gavras H. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system. J Am Coll Cardiol. 1986 Apr;7(4):758–765. doi: 10.1016/s0735-1097(86)80333-3. [DOI] [PubMed] [Google Scholar]
  4. Eiskjaer H., Bagger J. P., Danielsen H., Jensen J. D., Jespersen B., Thomsen K., Sørensen S. S., Pedersen E. B. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system. Am J Physiol. 1991 Jun;260(6 Pt 2):F883–F889. doi: 10.1152/ajprenal.1991.260.6.F883. [DOI] [PubMed] [Google Scholar]
  5. Francis G. S., Benedict C., Johnstone D. E., Kirlin P. C., Nicklas J., Liang C. S., Kubo S. H., Rudin-Toretsky E., Yusuf S. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 1990 Nov;82(5):1724–1729. doi: 10.1161/01.cir.82.5.1724. [DOI] [PubMed] [Google Scholar]
  6. Francis G. S., Goldsmith S. R., Levine T. B., Olivari M. T., Cohn J. N. The neurohumoral axis in congestive heart failure. Ann Intern Med. 1984 Sep;101(3):370–377. doi: 10.7326/0003-4819-101-3-370. [DOI] [PubMed] [Google Scholar]
  7. Francis G. S., Siegel R. M., Goldsmith S. R., Olivari M. T., Levine T. B., Cohn J. N. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med. 1985 Jul;103(1):1–6. doi: 10.7326/0003-4819-103-1-1. [DOI] [PubMed] [Google Scholar]
  8. Goldsmith S. R., Francis G., Cohn J. N. Attenuation of the pressor response to intravenous furosemide by angiotensin converting enzyme inhibition in congestive heart failure. Am J Cardiol. 1989 Dec 1;64(19):1382–1385. doi: 10.1016/0002-9149(89)90588-2. [DOI] [PubMed] [Google Scholar]
  9. Marcus M. L., Chilian W. M., Kanatsuka H., Dellsperger K. C., Eastham C. L., Lamping K. G. Understanding the coronary circulation through studies at the microvascular level. Circulation. 1990 Jul;82(1):1–7. doi: 10.1161/01.cir.82.1.1. [DOI] [PubMed] [Google Scholar]
  10. Neumann J., Schmitz W., Scholz H., von Meyerinck L., Döring V., Kalmar P. Increase in myocardial Gi-proteins in heart failure. Lancet. 1988 Oct 22;2(8617):936–937. doi: 10.1016/s0140-6736(88)92601-3. [DOI] [PubMed] [Google Scholar]
  11. Ogawa K., Ito T., Hashimoto H., Ito Y., Ohno O., Tsuboi H., Takasu N., Tanahashi T., Satake T. Plasma atrial natriuretic factor in congestive heart failure. Lancet. 1986 Jan 11;1(8472):106–106. doi: 10.1016/s0140-6736(86)90764-6. [DOI] [PubMed] [Google Scholar]
  12. Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation. 1988 Apr;77(4):721–730. doi: 10.1161/01.cir.77.4.721. [DOI] [PubMed] [Google Scholar]
  13. Packer M. Pathophysiology of chronic heart failure. Lancet. 1992 Jul 11;340(8811):88–92. doi: 10.1016/0140-6736(92)90405-r. [DOI] [PubMed] [Google Scholar]
  14. Packer M. Treatment of chronic heart failure. Lancet. 1992 Jul 11;340(8811):92–95. doi: 10.1016/0140-6736(92)90406-s. [DOI] [PubMed] [Google Scholar]
  15. Raine A. E., Erne P., Bürgisser E., Müller F. B., Bolli P., Burkart F., Bühler F. R. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med. 1986 Aug 28;315(9):533–537. doi: 10.1056/NEJM198608283150901. [DOI] [PubMed] [Google Scholar]
  16. Ritz E., Fliser D. The kidney in congestive heart failure. Eur Heart J. 1991 Aug;12 (Suppl 100):14–20. doi: 10.1093/eurheartj/12.suppl_c.14. [DOI] [PubMed] [Google Scholar]
  17. Sinoway L., Minotti J., Musch T., Goldner D., Davis D., Leaman D., Zelis R. Enhanced metabolic vasodilation secondary to diuretic therapy in decompensated congestive heart failure secondary to coronary artery disease. Am J Cardiol. 1987 Jul 1;60(1):107–111. doi: 10.1016/0002-9149(87)90995-7. [DOI] [PubMed] [Google Scholar]
  18. van Zwieten P. A. Comparative mechanisms of action of diuretic drugs in hypertension. Eur Heart J. 1992 Dec;13 (Suppl G):2–4. doi: 10.1093/eurheartj/13.suppl_g.2. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES